Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.
about
Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal actionSSD1 is integral to host defense peptide resistance in Candida albicans.Perspectives for clinical use of engineered human host defense antimicrobial peptidesPotent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanismCandidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.Oral health promotion interventions on oral yeast in hospitalised and medically compromised patients: a systematic review.The novel Candida albicans transporter Dur31 Is a multi-stage pathogenicity factor.Masking of β(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine.Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva.Antimicrobial peptides in the oral environment: expression and function in health and disease.New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.Bcr1 functions downstream of Ssd1 to mediate antimicrobial peptide resistance in Candida albicans.Candida albicans cell wall proteinsTh17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils.Interplay between Candida albicans and the antimicrobial peptide armory.Moonlighting proteins as virulence factors of pathogenic fungi, parasitic protozoa and multicellular parasites.Intracellular Targeting Mechanisms by Antimicrobial PeptidesSequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools.ISSLS PRIZE IN CLINICAL SCIENCE 2017: Is infection the possible initiator of disc disease? An insight from proteomic analysis.A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin.IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans.Human beta-defensins: differential activity against candidal species and regulation by Candida albicans.Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides.The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3.Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii).
P2860
Q28205819-8E6736F6-6063-4280-837B-8CA39924CE43Q29871517-5DE644B8-F2ED-4626-B769-19CEB2D0FDADQ33339288-58BFCC47-FF5F-427F-AEA0-C1BF58CBC6DDQ33700825-B19D2DC1-E906-475E-9234-63EBC78274D4Q33849225-D7A87133-508B-4B03-A8C1-5215C0EF8FEEQ33927464-F951B4F8-848B-48F8-8C9D-9ABF77D0F111Q33952105-0A85C392-BF87-4CE5-9D40-7EB438B41A75Q33958720-20B32CE1-C3E8-4A8D-AC05-296CF6F06B8FQ34205894-59BBF046-ED87-4158-8B7D-8EE7A1FAE237Q34298661-7E8B52BB-0F7D-48AF-A62D-B85120010A92Q34301662-07345437-7413-4495-81A5-58ECE22C123EQ34519189-EF601353-E4A1-4DAB-BA4E-3670A3C14399Q34528899-FD011BCD-6751-4A19-8587-A1036FA31B63Q34684398-8241AD92-E259-41CE-BC83-DB774FE524C1Q35057902-92C3454C-75CF-4520-AFBA-CACD44566A07Q36776474-DE1064DE-2ECC-4223-98F4-127128E9DCD3Q36898587-EC65D988-0D39-4EF9-BAE5-4335C98C9158Q37106755-D0974BA7-2ABF-426D-986C-B260203E32CEQ37111268-9E78A9E1-16C9-48B2-AC47-0213E337F0F2Q37594974-8C5C7F15-5A85-4710-8B53-E7A66BC8A800Q38222087-90DA6FAE-E611-41DE-975E-15298EDB5B0AQ38240717-D8CAED41-5A59-41C3-8B8F-861C10BD327DQ38760670-F07FE43D-5E4E-4D21-ABC5-F890549BC9ECQ38802524-E9D21F94-A8C9-40A5-AEF0-4D298D59427BQ38975008-877569CE-14E1-4971-B5FE-9949AC8D3D02Q39252818-126BC00E-35B2-44EA-A195-EDB7E58F01ABQ39651994-BEA7898E-18EC-43F4-AAAE-2584ABA1AD62Q40421383-A0181B49-91F1-430E-9348-D75352421C1EQ40424835-885CED73-3296-4848-ACE9-53033393EA94Q40433088-98DD3F84-47F3-4B80-995A-17286BAA0CBAQ40638341-821BC905-8677-478A-9BC2-6FD2226C9C34Q40730220-C9A54538-7DB6-4CA0-B8B2-8649BE624673Q41342515-0D205B54-F6D1-4AE0-BC08-5AB52F4B397FQ46460554-DABF4498-0136-4ABA-8524-1A119244D590
P2860
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Salivary histatin 5 and human ...... albicans via shared pathways.
@ast
Salivary histatin 5 and human ...... albicans via shared pathways.
@en
type
label
Salivary histatin 5 and human ...... albicans via shared pathways.
@ast
Salivary histatin 5 and human ...... albicans via shared pathways.
@en
prefLabel
Salivary histatin 5 and human ...... albicans via shared pathways.
@ast
Salivary histatin 5 and human ...... albicans via shared pathways.
@en
P2093
P2860
P1476
Salivary histatin 5 and human ...... a albicans via shared pathways
@en
P2093
M Edgerton
M W Araujo
S E Koshlukova
P2860
P304
P356
10.1128/AAC.44.12.3310-3316.2000
P407
P577
2000-12-01T00:00:00Z